Home » Topics » Regulatory

Regulatory
RSS

Regeneron claims novel use for neurotrophic factor

Dec. 23, 1996

Spray formulation of antimigraine Rx cleared for marketing

Dec. 20, 1996

Advisory committee recommends approval of non-nicotine smoking cessation product

Dec. 13, 1996

First marketing approval for Allergan antipsoriatic

Dec. 13, 1996

5-LO inhibitor approved by FDA

Dec. 13, 1996

First approval for Pharmacyclics' MRI contrast agent

Dec. 12, 1996

NMDA antagonists ameliorate ototoxicity of aminoglycoside antibiotics

Dec. 12, 1996

Janssen files for lower-dose risperidone in U.S.

Dec. 12, 1996

Cholesterol-lowering statin approved in first markets

Dec. 11, 1996

OsmoCyte approved for marketing in U.S.

Dec. 9, 1996